Michael R. Gold

Active 1987–2025

Also published as
Michael R Gold
168
Papers
31,133
Citations
97
h-index
166
i10-index

Citations

Citations per year for Michael R. Gold1971: 1 citations1987: 1 citations1989: 6 citations1990: 9 citations1991: 30 citations1992: 36 citations1993: 57 citations1994: 71 citations1995: 65 citations1996: 64 citations1997: 60 citations1998: 80 citations1999: 77 citations2000: 94 citations2001: 94 citations2002: 129 citations2003: 115 citations2004: 108 citations2005: 120 citations2006: 120 citations2007: 79 citations2008: 85 citations2009: 94 citations2010: 123 citations2011: 109 citations2012: 182 citations2013: 169 citations2014: 207 citations2015: 187 citations2016: 165 citations2017: 220 citations2018: 169 citations2019: 613 citations2020: 644 citations2021: 700 citations2022: 538 citations2023: 485 citations2024: 884 citations2025: 408 citations2026: 18 citations1972–1986: no citations, so these years are not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,676 citing papers, 24.7% of this breakdownUnited Kingdom: 767 citing papers, 7.1% of this breakdownGermany: 688 citing papers, 6.4% of this breakdownCanada: 674 citing papers, 6.2% of this breakdownItaly: 605 citing papers, 5.6% of this breakdownNetherlands: 500 citing papers, 4.6% of this breakdownChina: 493 citing papers, 4.6% of this breakdownFrance: 404 citing papers, 3.7% of this breakdownJapan: 304 citing papers, 2.8% of this breakdownSpain: 301 citing papers, 2.8% of this breakdownAustralia: 292 citing papers, 2.7% of this breakdownDenmark: 266 citing papers, 2.5% of this breakdown
0%24.7%Other 26.3%

Fields

  • Medicine64.7%
  • Immunology and Microbiology16.1%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Neuroscience2.8%
  • Engineering0.9%
  • Agricultural and Biological Sciences0.7%
  • Other1.9%

Topics

  • Cardiac pacing and defibrillation studies9.5%
  • Cardiac Arrhythmias and Treatments6.4%
  • Atrial Fibrillation Management and Outcomes6%
  • Cardiac electrophysiology and arrhythmias5.5%
  • Antimicrobial Peptides and Activities2.3%
  • Immune Response and Inflammation2.3%
  • Other68%

Coauthors

All papers

Open in search
  1. Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta Pombo, Félix Ayala-Paredes, Lizhen Xu, K Simek, Sandra Nevills, Rajibul Mian, Stuart J. Connolly - New England Journal of Medicine 2023 cited by 415

  2. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valentina Kutyifa, Mark S. Link, Joseph E. Marine, Wilfried Müllens, Seung‐Jung Park, Ratika Parkash, Manuel Patete, Rajeev K. Pathak, Carlos Perona, John Rickard, Mark H. Schoenfeld, Swee‐Chong Seow, Win‐Kuang Shen, Morio Shoda, Jagmeet P. Singh, David J. Slotwiner, Arun Raghav Mahankali Sridhar, Uma N. Srivatsa, Eric C. Stecker, Tanyanan Tanawuttiwat, W.H. Wilson Tang, Carlos A. Tapias, Cynthia M. Tracy, Gaurav A. Upadhyay, Niraj Varma, Kevin Vernooy, Pugazhendhi Vijayaraman, Sarah Ann Worsnick, Wojciech Zaręba, Emily P. Zeitler - Heart Rhythm 2023 cited by 483

  3. Subclinical Atrial Fibrillation and the Risk of Stroke

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 2,085

  4. An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patricia Zwierzchowski, Joshua Scurll, Vincent Fung, Sonia Black, N.C.J. Strynadka, Michael R. Gold, Leonard G. Presta, Gordon Ng, Surjit B. Dixit - Nature Communications 2023 cited by 163

  5. Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2022 cited by 338

  6. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT

    Authors: , , , , , , , , , , , - European Heart Journal 2017 cited by 597

  7. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay

    Authors: , , , , , , , , , , , , , , , , , , - Heart Rhythm 2018 cited by 975

  8. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial

    Authors: , , , , , , , , , , , , , , , - Circulation 2021 cited by 389

  9. Vagus Nerve Stimulation for the Treatment of Heart Failure

    Authors: , , , , , , , , , , , , - Journal of the American College of Cardiology 2016 cited by 385

  10. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 593

  11. Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms

    Authors: , , , , , - Journal of the American College of Cardiology 2008 cited by 1,256

  12. Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events

    Authors: , , , , , , , , , , , , , , , , - Circulation 2014 cited by 670

  13. The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses

    Authors: , , , , - The Journal of Immunology 2002 cited by 708

  14. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2011 cited by 838

  15. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

    Authors: , , , , , , , , - European Heart Journal 2013 cited by 521

  16. Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2024 cited by 69

  17. Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 cited by 144

  18. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naiara Calvo, Christopher Cassidy, Michel Chauvin, Halim Marzak, Jason S. Chinitz, Allen Ciuffo, Jude Clancy, Karl J. Crossen, Paolo De Filippo, Fausto Devecchi, Sreekanth Karanam, Rahul N. Doshi, Lars Eckardt, Matthew Fedor, Roger A. Freedman, Anil K. Gehi, Peter Goethals, Nils Gosau, Charles Gottlieb, Gregory Granrud, Radmira Greenstein, Firas Hamdan, Sam Hanon, Alborz Hassankhani, Rick Henderson, Stefan H. Hohnloser, David T. Huang, Didier Irles, Gautham Kalahasty, Pedram Kazemian, Farhat Khairallah, Brian Kim, Edward Kim, Christoph A. Klein, Bradley P. Knight, Niuton Koide, Richard Kuk, Christophe Leclercq, Michael Lee, Shang-Chiun Lee, Corinna Lenz, Nigel Lewis, Robert K. Lewis, George E. Mark, Christelle Marquié, Kelly M. W. McDonnell, John P. McKenzie, Faisal M. Merchant, Sameh Mobarek, Tiziano Moccetti, Franck Molin, Francois Philliopon, Giovanni Morani, Daniel P. Morin, G. André Ng, Emmanuel Nsah, Manoj Panday, Jean‐Luc Pasquié, Nicasio Castellano Perez, Francisco Perez-Gil, Paweł Ptaszyński, Anil Rajendra, Troy E. Rhodes, Paul R. Roberts, Steven K. Rowe, Samir Saba, Venkata Sagi, Brian H. Sarter, John A. Schoenhard, John J. Schutzman and 21 more - Circulation 2020 cited by 218

  19. Phase separation and clustering of an ABC transporter in Mycobacterium tuberculosis

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 88

  20. Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator

    Authors: , , , , , , , , , , , - Circulation 2013 cited by 553

  21. Control of the Hippo Pathway by Set7-Dependent Methylation of Yap

    Authors: , , , , , , , , , , , , , , , - Developmental Cell 2013 cited by 161

  22. The Interaction of Sex, Height, and QRS Duration on the Effects of Cardiac Resynchronization Therapy on Morbidity and Mortality: An Individual-Patient Data Meta-Analysis

    Authors: , , , , , , , - European Journal of Heart Failure 2018 cited by 112

  23. The evolving state of cardiac resynchronization therapy and conduction system pacing: 25 years of research at EP Europace journal

    Authors: , , , , , , , , , - EP Europace 2023 cited by 58

  24. Left Bundle Branch Pacing

    Authors: , , - Journal of the American College of Cardiology 2019 cited by 210